Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
YMAB
YMAB News & Events
-
Add to Watchlist
Trade YMAB
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
YMAB News
SHAREHOLDER INQUIRY: Halper Sadeh LLC Probes VRNT, DAY, WOW, YMAB for Shareholder Interests
Aug 26 2025
Globenewswire
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving Verint Systems Inc. (Nasdaq – VRNT), Dayforce, Inc. (NYSE – DAY), WideOpenWest, Inc. (NYSE – WOW), and Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
Aug 26 2025
Globenewswire
SHAREHOLDER INQUIRY: Halper Sadeh LLC Probes DAY, WOW, YMAB, STAA for Shareholder Interests
Aug 21 2025
Globenewswire
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), and Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
Aug 21 2025
Globenewswire
SHAREHOLDER INQUIRY: Halper Sadeh LLC Probes VBTX, TASK, YMAB for Shareholder Interests
Aug 20 2025
Globenewswire
Investor Alert on Y-MABS Therapeutics: Kahn Swick & Foti, LLC, Led by Former Louisiana Attorney General, Examines Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB
Aug 19 2025
Globenewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DNOW, TASK, YMAB on Behalf of Shareholders
Aug 18 2025
PRnewswire
$HAREHOLDER ALERT: M&A Class Action Firm Ongoing Investigation into the Merger of DNOW, TASK, SQCF, and YMAB
Aug 18 2025
Globenewswire
Show More News
YMAB Events
08/08 06:43
Y-mAbs Therapeutics reports Q2 EPS (7c), consensus (25c)
Reports Q2 revenue $19.5M, consensus $18.4M.
Show More Events
YMAB Monitor News
No data
YMAB Earnings Analysis
No Data
People Also Watch
